Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on May 27, 2020 and is headquartered in New York, NY.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Apexigen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Apexigen Inc market cap is $9.57M.
What is the 52-week high for Apexigen Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Apexigen Inc 52 week high is $8.28 as of September 24, 2025.
What is the 52-week low for Apexigen Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Apexigen Inc 52 week low is $0.3305 as of September 24, 2025.
What is Apexigen Inc stock price today?
Apexigen Inc stock price today is $0.3851.
What was Apexigen Inc stock price yesterday?
Apexigen Inc stock price yesterday was $0.355.
What is the Price-to-Book ratio of Apexigen Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Apexigen Inc P/B ratio is 0.0515.
What is the 50-day moving average of Apexigen Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Apexigen Inc 50-day moving average is $0.4259.